July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Robert Daly: Thank you for the mentorship and collaboration of the MATCHES Center team
Jun 6, 2024, 12:42

Robert Daly: Thank you for the mentorship and collaboration of the MATCHES Center team

Robert Daly, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post by Memorial Sloan Kettering Cancer Center, on LinkedIn, adding:

”Thank you for the mentorship and collaboration of the MATCHES Center team: Michael Morris, Deb Schrag, Katherine Panageas, Peter D. Stetson, Erin Bange, Sahil Doshi, Allison Lipitz Synderman, Fernanda C. G. Polubriaginof, Gilad Kuperman, Charlotte Malling, Leslie Cheteyan, Andrea D’Agostino, Camila Bernal, Jill Ackerman, Eric Froehlich, Michelle Levy, Erin McGarry and our amazing patients and caregivers.”

Quoting Memorial Sloan Kettering Cancer Center’s post:

Robert Daly, a thoracic oncologist at Memorial Sloan Kettering (MSK), presented clinical trial research delivering high quality cancer care at home by integrating telemedicine into both immunotherapy treatment and integrative medicine at the American Society of Clinical Oncology (ASCO) Annual Meeting.

‘The next frontier is delivering safe and effective treatment at home, which can help patients and care givers by making care less stressful and reducing concerns like time and financial toxicities that limit people‚Äôs access to high quality care,’ Dr. Daly says.

Learn more about both of these research projects.”

Source: Robert Daly/LinkedIn and Memorial Sloan Kettering Cancer Center/LinkedIn

Founded in 1884 Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a renowned cancer treatment and research facility located in Manhattan, New York City. With over 120 research laboratories, it is globally recognized for its dynamic cancer research program. MSK has pioneered numerous treatment advances, including radiation therapy, chemotherapy, immunotherapy, and precision medicine. Recent successes include the development of checkpoint inhibitors and CAR T cells. For over 30 years, MSK has consistently been ranked the second-best hospital for cancer care in the US by U.S. News & World Report’s Best Hospitals rankings.